Epithelial inflammation is associated with CCL28 production and the recruitment of regulatory T cells expressing CCR10

Journal of Immunology

Volumn 177, Issue 1, 2006, Pages 593-603

  Eksteen, Bertus ^a   Miles, Alice ^a   Curbishley, Stuart M ^a   Tselepis, Chris ^a   Grant, Allister J ^a   Walker, Lucy S K ^a   Adams, David H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADDRESSIN; BILE ACID; CD4 ANTIGEN; CELL ADHESION MOLECULE; CHEMOKINE; CHEMOKINE CCL28; CHEMOKINE RECEPTOR CCR10; CHEMOKINE RECEPTOR CCR7; CHEMOKINE RECEPTOR CXCR3; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; LIPOPOLYSACCHARIDE; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG; VASCULAR CELL ADHESION MOLECULE 1;

ANTIINFLAMMATORY ACTIVITY; ARTICLE; BILE DUCT; CELL ADHESION; CHRONIC HEPATITIS; CONTROLLED STUDY; EPITHELIUM; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; IMMUNOSURVEILLANCE; INFLAMMATION; LYMPHOCYTE MIGRATION; MUCOSAL IMMUNITY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; SUPPRESSOR CELL; WESTERN BLOTTING;

EID: 33745298438     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.1.593     Document Type: Article

References (51)

1. + regulatory T cells for immunologic self-tolerance and negative control of immune responses. Annu. Rev. Immunol. 22: 531-562.
2. + regulatory T cells in vivo. J. Exp. Med. 198: 249-258.
3. + regulatory T cells in the steady state. J. Exp. Med. 198: 737-746.
4. Kronenberg, M., and A. Rudensky. 2005. Regulation of immunity by self-reactive T cells. Nature 435: 598-604.
5. + T cell receptors. Immunity 21: 267-277.
6. Hori, S., T. Nomura, and S. Sakaguchi. 2003. Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
7. + T regulatory cells. Nat. Immunol. 4: 337-342.
8. Tirol, E. A., F. Borriello, A. N. Schweitzer, W. P. Lynch, J. A. Bluestone, and A. H. Sharpe. 1995. Loss of CTLA-4 leads to massive lymphoproliferation and fatal multiorgan tissue destruction, revealing a critical negative regulatory role of CTLA-4. Immunity 3: 541-547.
9. + resting regulatory T cells from activated T cells. J. Immunol. 176: 2808-2816.
10. + regulatory T cells is mediated by cell surface-bound transforming growth factor β. J. Exp. Med. 194: 629-644.
11. Asseman, C., S. Mauze, M. W. Leach, R. L. Coffman, and F. Powrie. 1999. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190: 995-1004.
12. + regulatory T cells. J. Immunol. 170: 3939-3943.
13. Eksteen, B., L. S. Walker, and D. H. Adams. 2005. Immune regulation and colitis: suppression of acute inflammation allows the development of chronic inflammatory bowel disease. Gut 54: 4-6.
14. MacDonald, T. T., and G. Monteleone. 2005. Immunity, inflammation, and allergy in the gut. Science 307: 1920-1925.
15. Belkaid, Y., and B. T. Rouse. 2005. Natural regulatory T cells in infectious disease. Nat. Immunol. 6: 353-360.
16. - memory T helper cells. BMC Immunol. 5: 13.
17. Kunkel, E. J., C. H. Kim, N. H. Lazarus, M. A. Vierra, D. Soler, E. P. Bowman, and E. C. Butcher. 2003. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 111: 1001-1010.
18. Wang, W., H. Soto, E. R. Oldham, M. E. Buchanan, B. Homey, D. Catron, N. Jenkins, N. G. Copeland, D. J. Gilbert, N. Nguyen, et al. 2000. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J. Biol. Chem. 275: 22313-22323.
19. Soler, D., T. L. Humphreys, S. M. Spinola, and J. J. Campbell. 2003. CCR4 versus CCR10 in human cutaneous Th lymphocyte trafficking. Blood 101: 1677-1682.
20. Ogawa, H., M. Iimura, L. Eckmann, and M. F. Kagnoff. 2004. Regulated production of the chemokine CCL28 in human colon epithelium. Am. J. Physiol. 287: G1062-G1069.
21. Hieshima, K., H. Ohtani, M. Shibano, D. Izawa, T. Nakayama, Y. Kawasaki, F. Shiba, M. Shiota, F. Katou, T. Saito, and O. Yoshie. 2003. CCL28 has dual roles in mucosal immunity as a chemokine with broad-spectrum antimicrobial activity. J. Immunol. 170: 1452-1461.
22. Müller, A., B. Homey, H. Soto, N. Ge, D. Catron, M. E. Buchanan, T. McClanahan, E. Murphy, W. Yuan, S. N. Wagner, et al. 2001. Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56.
23. Hwang, S. T. 2004. Chemokine receptors in melanoma: CCR9 has a potential role in metastasis to the small bowel. J. Invest. Dermatol. 122: xiv-xxv.
24. Lazarus, N. H., E. J. Kunkel, B. Johnston, E. Wilson, K. R. Youngman, and E. C. Butcher. 2003. A common mucosal chemokine (mucosae-associated epithelial chemokine/CCL28) selectively attracts IgA plasmablasts. J. Immunol. 170: 3799-3805.
25. 7, but not for homophilic adhesion. J. Immunol. 175: 1014-1021.
26. + regulatory T cells. J. Exp. Med. 199: 303-313.
27. Siegmund, K., M. Feuerer, C. Siewert, S. Ghani, U. Haubold, A. Dankof, V. Krenn, M. P. Schön, A. Scheffold, J. B. Lowe, et al. 2005. Migration matters: regulatory T-cell compartmentalization determines suppressive activity in vivo. Blood 106: 3097-3104.
28. + gut-homing lymphocytes to the liver in primary sclerosing cholangitis. J. Exp. Med. 200: 1511-1517.
29. Grant, A. J., P. F. Lalor, S. G. Hubscher, M. Briskin, and D. H. Adams. 2001. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease). Hepatology 33: 1065-1072.
30. Joplin, R., A. J. Strain, and J. M. Neuberger. 1989. Immune-isolation and culture of biliary epithelial-cells from normal human-liver. In Vitro Cell. Dev. Biol. 25: 1189-1192.
31. Burdick, M. D., S. L. Kunkel, P. M. Lincoln, C. A. Wilke, and R. M. Stricter. 1993. Specific ELISAs for the detection of human macrophage inflammatory protein-1α and β. Immunol. Invest. 22: 441-449.
32. Goddard, S., J. Youster, E. Morgan, and D. H. Adams. 2004. Interleukin-10 secretion differentiates dendritic cells from human liver and skin. Am. J. Pathol. 164:511-519.
33. Klugewitz, K., D. H. Adams, M. Emoto, K. Eulenburg, and A. Hamann. 2004. The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol. 25: 590-594.
34. + T cell mediated intestinal immunity: chronic inflammation versus immune regulation. Gut 54: 60-69.
35. Valmori, D., A. Merlo, N. E. Souleimanian, C. S. Hesdorffer, and M. Ayyoub. 2005. A peripheral circulating compartment of natural naive CD4 Tregs. J. Clin. Invest. 115: 1953-1962.
36. + T regulatory cells mediating allograft tolerance depends on the CCR4 chemokine receptor. J. Exp. Med. 201: 1037-1044.
37. + T cells depend on tissue origin and microbial stimulus. J. Immunol. 176: 557-566.
38. D'Ambrosio, D., F. Sinigaglia, and L. Adorini. 2003. Special attractions for suppressor T cells. Trends Immunol. 24: 122-126.
39. Curbishley, S. M., B. Eksteen, R. P. Gladue, P. Lalor, and D. H. Adams. 2005. CXCR3 activation promotes lymphocyte transendothelial migration across human hepatic endothelium under fluid flow. Am. J. Pathol. 167: 887-899.
40. + regulatory T cells. Hepatology 42: 193-199.
41. + cells controlling a pathogenic CD4 response inhibit cytokine differentiation, CXCR-3 expression, and tissue invasion. J. Immunol. 173: 2942-2951.
42. Bystry, R. S., V. Aluvihare, K. A. Welch, M. Kallikourdis, and A. G. Betz. 2001. B cells and professional APCs recruit regulatory T cells via CCL4. Nat. Immunol. 2: 1126-1132.
43. + regulatory T cells. J. Exp. Med. 194: 847-853.
44. Homey, B., H. Alenius, A. Müller, H. Soto, E. P. Bowman, W. Yuan, L. McEvoy, A. I. Lauerma, T. Assmann, E. Bünemann, et al. 2002. CCL27-CCR10 interactions regulate T cell-mediated skin inflammation. Nat. Med. 8: 157-165.
45. Mora, J. R., G. Cheng, D. Picarella, M. Briskin, N. Buchanan, and U. H. von Andrian. 2005. Reciprocal and dynamic control of CD8 T cell homing by dendritic cells from skin- and gut-associated lymphoid tissues. J. Exp. Med. 201: 303-316.
46. Sugimoto, K., F. Ikeda, J. Stadanlick, F. A. Nunes, H. J. Alter, and K. M. Chang. 2003. Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection. Hepatology 38: 1437-1448.
47. Unitt, E., S. M. Rushbrook, A. Marshall, S. Davies, P. Gibbs, L. S. Morris, N. Coleman, and G. J. Alexander. 2005. Compromised lymphocytes infiltrate hepatocellular carcinoma: the role of T-regulatory cells. Hepatology 41: 722-730.
48. + T cell population in chronic hepatitis C virus infection. J. Clin. Invest. 113: 963-972.
49. Aoki, C. A., C. L. Bowlus, and M. E. Gershwin. 2005. The immunobiology of primary sclerosing cholangitis. Autoimmun. Rev. 4: 137-143.
50. Nishio, A., E. B. Keeffe, and M. E. Gershwin. 2002. Immunopathogenesis of primary biliary cirrhosis. Semin. Liver Dis. 22: 291-302.
51. Bruder, D., A. M. Westendorf, R. Geffers, A. D. Gruber, M. Gereke, R. I. Enelow, and J. Buer. 2004. CD4 T Lymphocyte-mediated lung disease: steady state between pathological and tolerogenic immune reactions. Am. J. Respir. Crit. Care Med. 170: 1145-1152.